跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
YASMINELLE DIARIO 3 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
YASMINELLE DIARIO 3 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
YASMINELLE DIARIO 3 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Bayer Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 8, 2021
Approval ID
c99872609a4540c2
Company
Bayer Ab
Type
Standard
Approval Details
Approval Id
c99872609a4540c2
Drug Cima Aemps Name
YASMINELLE DIARIO 3 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
05-3805
Holder Company Name
Bayer Ab
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2021-01-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
3/0,02 mg/mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Bayer Ab
Active Ingredients
DROSPIRENONA
3 mg
ETINILESTRADIOL
0,020 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 8, 2021
Approval ID
c99872609a4540c2
Type
Standard
Back to CIMA-AEMPS Approvals